Probiotics for the prevention of Clostridium difficile associated diarrhea in adults and children

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Johnston, Brad C ^a   Thorlund, Kristian ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ADULT DISEASE; ANTIBIOTIC THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE INFECTION; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MORTALITY; REVIEW;

EID: 70249091426     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006095.pub2     Document Type: Review

References (16)

1. Amores R, Calvo A, Maestre J, Martínez-Hernández D. Probiotics [Probióticos]. Rev Esp Quimioter 2004;17(2):131-139
2. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346(5):334-339
3. Cremonini F, Di Caro S, Nista E, Bartolozzi F, Capelli G, Gasbarrini G, et al.Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002;16(8):1461-1467 (Pubitemid 34953587)
4. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic-associated diarrhoea: meta-analysis. BMJ 2002;324(7350):1361-1367 (Pubitemid 34628005)
5. Dendukuri N, Costa V, McGregor M, Brophy JM. Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review. CMAJ 2005;173(2):167-170 (Pubitemid 41032513)
6. Drisko J, Bischoff B, Giles C, Adelson M, Rao RV, McCallum R. Evaluation of five probiotics products for label claims by DNA extraction and polymerase chain reaction analysis. Dig Dis Sci 2005;50(6):1113-1117 (Pubitemid 40864017)
7. Gibson PR, Muir JG. Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?. Gut 2005;54(7):900-903
8. Gionchetti P, Lammers KM, Rizzello F, Campieri M. Probiotics and barrier function in colitis. Gut 2005;54(7):898-900.
9. Hart AL, Stagg AJ, Frame M, Graffner H, Glise H, Falk P, et al.The role of the gut flora in health and disease, and its modification as therapy. Aliment Pharmacol Ther 2002;16(8):1383-1393 (Pubitemid 34953580)
10. Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org, 2008.
11. Kyne L, Kelly C. Recurrent Clostridium difficile diarrhoea. Gut 2001;49(1):152-153
12. McFarland LV, Surawicz CM, Greenberg RN, Fekely R, Elmer GW, Moyer KA, et al.A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271(24):1913-1918
13. Rolfe R. The role of probiotics cultures in the control of gastrointestinal health. J Nutr 2000;130(2S Suppl):396S-402S. (Pubitemid 30073758)
14. Sullivan A, Nord C. Probiotics in human infections. J Antimicrob Chemother 2002;50(5):625-627
15. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al.The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000;31(4):1012-1017 (Pubitemid 32299362)
16. Worsley MA. Infection control and prevention of Clostridium difficile infection. J Antimicrob Chemother 1998;41 Suppl C:59-66.